A cost-effectiveness analysis of rivaroxaban in combination with acetylsalicylic acid (ASA) in adult patients with coronary artery disease (CAD) or symptomatic peripheral artery disease (PAD) at high risk of ischaemic events

B. Pinheiro, M. Gouveia, J. Alarcão, R. Ascenção, M. Borges

Resultado de pesquisarevisão de pares

Resultados da pesquisa